Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Dermatology

    Tag: Dermatology

    You Searched For "Dermatology"
    Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit

    Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit

    Medical Dialogues Bureau29 July 2019 9:17 AM IST
    Novartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
    Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm

    Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm

    Medical Dialogues Bureau10 July 2019 10:04 AM IST
    The Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    GSK Pharma to optimise product portfolio to drive growth in India

    GSK Pharma to optimise product portfolio to drive growth in India

    Medical Dialogues Bureau24 Jun 2019 9:19 AM IST
    GSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Farhat Nasim10 Jun 2019 2:02 PM IST
    The detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Meghna A Singhania29 May 2019 2:37 PM IST
    New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    Meghna A Singhania22 May 2019 5:25 PM IST
    New Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
    Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

    Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

    Farhat Nasim2 March 2019 11:00 AM IST
    "Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...
    Sun Pharma to acquire Japan

    Sun Pharma to acquire Japan's Pola Pharma for Rs 7 crores approx

    Medical Dialogues Bureau27 Nov 2018 4:20 PM IST
    New Delhi: Sun Pharma on Monday said it will acquire Japan-based Pola Pharma for around USD 1 million, (approximately Rs 7 crores) to strengthen its...
    Novartis generics arm says may sell or end some products

    Novartis generics arm says may sell or end some products

    Ruby Khatun Khatun18 Dec 2017 9:30 AM IST
    ZURICH: Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok